Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.19% |
| 2 | Financials | 11.87% |
| 3 | Industrials | 10.26% |
| 4 | Energy | 9.33% |
| 5 | Technology | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAV
3201
DELISTED
Advantage Oil & Gas Ltd
AAV
| $91K | ﹤0.01% |
+13,496
| New | +$94.6K |
|
|
ALPN
3202
DELISTED
Alpine Immune Sciences Inc
ALPN
| $90K | ﹤0.01% |
+10,021
| New | +$200K |
|
3203
Harvard Bioscience
HBIO
$27.1M
| $88K | ﹤0.01% |
2,897
-1,713
| -37% | -$43.6K |
|
3204
Asure Software
ASUR
$220M
| $86K | ﹤0.01% |
+10,066
| New | +$78.6K |
|
|
MCN
3205
Madison Covered Call & Equity Strategy Fund
MCN
$117M
| $85K | ﹤0.01% |
+11,077
| New | +$86.2K |
|
3206
Enphase Energy
ENPH
$4.84B
| $84K | ﹤0.01% |
83,369
-46,131
| -36% | -$52.9K |
|
|
UNIS
3207
DELISTED
Unilife Corporation
UNIS
| $82K | ﹤0.01% |
35,869
-27,931
| -44% | -$65.4K |
|
|
STKL
3208
DELISTED
SunOpta
STKL
| $81K | ﹤0.01% |
+11,521
| New | +$80.2K |
|
|
TRIL
3209
DELISTED
Trillium Therapeutics Inc.
TRIL
| $81K | ﹤0.01% |
14,300
-2,910
| -17% | -$29K |
|
|
DWCH
3210
DELISTED
Datawatch Corp
DWCH
| $80K | ﹤0.01% |
+14,491
| New | +$96.1K |
|
3211
Zevra Therapeutics
ZVRA
$563M
| $79K | ﹤0.01% |
1,665
+100
| +6% | +$6.14K |
|
|
HIVE
3212
DELISTED
Aerohive Networks
HIVE
| $79K | ﹤0.01% |
13,776
-160,340
| -92% | -$887K |
|
|
SEAC
3213
DELISTED
Seachange International Inc
SEAC
| $77K | ﹤0.01% |
1,663
-6,437
| -79% | -$336K |
|
|
PTN
3214
Palatin Technologies
PTN
$13.7M
| $76K | ﹤0.01% |
+120
| New | +$83.5K |
|
3215
SCYNEXIS
SCYX
$37M
| $74K | ﹤0.01% |
291
-157
| -35% | -$46K |
|
3216
Compugen
CGEN
$216M
| $73K | ﹤0.01% |
14,328
-78,392
| -85% | -$469K |
|
|
SRRA
3217
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $73K | ﹤0.01% |
+1,225
| New | +$76.4K |
|
|
IVTY
3218
DELISTED
Invuity, Inc
IVTY
| $72K | ﹤0.01% |
12,479
-10,816
| -46% | -$90.5K |
|
3219
Cytosorbents Corp
CTSO
$22.6M
| $71K | ﹤0.01% |
+13,000
| New | +$71.2K |
|
3220
GEE Group
JOB
$23.4M
| $71K | ﹤0.01% |
16,041
-8,320
| -34% | -$39.5K |
|
3221
Codexis
CDXS
$135M
| $70K | ﹤0.01% |
15,112
-32,139
| -68% | -$151K |
|
|
WORX
3222
DELISTED
SCWORX CORP NEW
WORX
| $70K | ﹤0.01% |
+4
| New | +$68K |
|
3223
Zedge
ZDGE
$38.9M
| $69K | ﹤0.01% |
21,885
-10,059
| -31% | -$32.4K |
|
|
YDKG
3224
Yueda Digital Holding
YDKG
$5M
| $68K | ﹤0.01% |
+14
| New | +$82.2K |
|
|
GFN
3225
DELISTED
General Finance Corporation
GFN
| $68K | ﹤0.01% |
+12,218
| New | +$55K |
|
Similar funds
Millennium Management's Q4 2016 Portfolio in Review
As of Q4 2016, Millennium Management held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Millennium Management withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Financials and Industrials.
Against the trend, Millennium Management opened a new position in Target worth $175M.
- Millennium Management's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Millennium Management added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Millennium Management's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Millennium Management fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Millennium Management's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Millennium Management opened 858 new positions and closed 801 in Q4 2016.
- Millennium Management's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.